AMENDED AND RESTATED EXCLUSIVE WHOLESALE PRODUCT PURCHASE AGREEMENTExclusive Wholesale Product Purchase Agreement • August 9th, 2012 • Corcept Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 9th, 2012 Company Industry JurisdictionTHIS AMENDED AND RESTATED EXCLUSIVE WHOLESALE PRODUCT PURCHASE AGREEMENT (the “Agreement”) is made this 8th day of August, 2012, effective as of the 1st day of March, 2012, (the “Effective Date”) by and between Priority Healthcare Distribution, Inc., doing business as CuraScript SD Specialty Distribution, a Florida corporation having offices at 255 Technology Park, Lake Mary, Florida, 32746 (“Distributor”), and Corcept Therapeutics Incorporated, a Delaware corporation having offices at 149 Commonwealth Drive, Menlo Park, CA 94025 (“Company”). The Parties hereto agree as follows:
COMMERCIAL OUTSOURCING SERVICES AGREEMENTCommercial Outsourcing Services Agreement • August 9th, 2012 • Corcept Therapeutics Inc • Pharmaceutical preparations • Texas
Contract Type FiledAugust 9th, 2012 Company Industry JurisdictionThis Commercial Outsourcing Services Agreement (“Agreement”) is entered into as of April 14, 2011 (the “Effective Date”) by INTEGRATED COMMERCIALIZATION SOLUTIONS, INC., a California corporation (“ICS”) and Corcept Therapeutics, INC., a Delaware corporation (the “Company”).
AMENDED AND RESTATED EXCLUSIVE PHARMACY PRODUCT PURCHASE AND SERVICE AGREEMENTExclusive Pharmacy Product Purchase and Service Agreement • August 9th, 2012 • Corcept Therapeutics Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 9th, 2012 Company Industry JurisdictionTHIS AMENDED AND RESTATED EXCLUSIVE PHARMACY PRODUCT PURCHASE AND SERVICE AGREEMENT (the “Agreement”) is made this 8th day of August, 2012, effective as of the 3rd day of January, 2012, (the “Effective Date”) by and among CuraScript, Inc., a Delaware corporation having offices located at 6272 Lee Vista Blvd., Orlando, Florida 32822 (“CuraScript”) and its affiliate Express Scripts Specialty Distribution Services, Inc., a Delaware corporation with offices at One Express Way, St. Louis, MO 63121 (“ESSDS”) referred to herein collectively as (“CuraScript/ESSDS”), and Corcept Therapeutics Incorporated, a Delaware corporation having offices at 149 Commonwealth Drive, Menlo Park, CA 94025 (“Company”). The Parties hereto agree as follows: